Molbio Diagnostics and Dhoot Transmission shares to be listed on NSE on August 17
Shares of two new companies will be available for trading in India's primary market from August 17, 2026. This listing applies to all investors under the compulsory demat and rolling settlement system in the normal market segment.
Highlights
- Equity shares of Molbio Diagnostics Limited and Dhoot Transmission Limited will be listed and available for trading on NSE from August 17, 2026.
- Shares of both companies will be traded on NSE in the EQ series under Compulsory Demat mode and Normal Market segment.
- This listing will provide investors with the opportunity for secondary market transactions and price discovery in the shares, thereby increasing liquidity.
This article was translated from the original. Read the original version by our correspondent here.
Listing Timeline and Trading Arrangement
According to the notification from the National Stock Exchange of India, equity shares of Molbio Diagnostics Limited and Dhoot Transmission Limited will be listed and admitted to dealings on the exchange from August 17, 2026. Trading in both shares will take place in the Normal Market segment on a Compulsory Demat basis.The trading symbol for Molbio Diagnostics Limited is MOLBIO and its series will be EQ. The company's ISIN code is INE869T01028, while Dhoot Transmission Limited's trading symbol is DHOOTTRANS, series EQ, and ISIN code INE01NH01023.
Significance for Investors and the Market
This listing provides investors with the opportunity for formal secondary market trading in the shares of both companies, initiating the process of price discovery and liquidity. The compulsory demat and rolling settlement system ensures settlement of trades within the standard exchange framework.This update, issued from Mumbai on August 14, 2026, indicates that the exchange has approved both companies' shares for dealings from the specified date. From August 17, investors will be able to trade these securities regularly on the NSE platform.
Our previous report covered the listing of Molbio Diagnostics Limited and Dhoot Transmission Limited shares on NSE from August 17, 2026 and the commencement of trading. It stated that both companies' equity shares will be traded in the EQ series in the normal market segment under compulsory demat and rolling settlement, enhancing liquidity and price discovery in the secondary market.
Latest Interactive Brokers News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
